Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Retatrutide (also known as LY3437943) is an investigational medication developed by Eli Lilly that activates three key metabolic receptors : GLP-1 (glucagon-like peptide-1): reduces appetite and improves blood sugar control GIP (glucose-dependent insulinotropic polypeptide): enhances insulin response Glucagon receptor: increases energy expenditure and fat metabolism This triple-hormone weight loss drug approach creates a balanced effect, suppressing hunger and increasing calorie burn, something earlier GLP-1 medications couldnt fully achieve
Sep 2021;14(3):208-217
S.LiptonJ.et al
Atri A, Molinuevo JL, Lemming O, Wirth Y, Pulte I, Wilkinson D
US$ 26.50
US$ 22.02
US$ 21.21
US$ 23.07
US$ 27.82
